Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GN-037 cream in mild to moderate plaque psoriasis
NCT05706870Phase 2Completed
- Sponsor
- Gen Ilac Ve Saglik Urunleri
- Start
- Dec 2022
- Primary completion
- Jan 2024
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of GN-037 in plaque psoriasis, sponsored by Gen Ilac Ve Saglik Urunleri. Started Dec 2022; status: completed.
02
Drugs
GN-037
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05706870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706870.